You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 259 No. 22, June 10, 1988 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (94)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Characterization of Antihypertensive Therapy by Whole-Day Blood Pressure Monitoring

Michael A. Weber, MD; Deanna G. Cheung, MD; William F. Graettinger, MD; Jodi L. Lipson, MPH

JAMA. 1988;259(22):3281-3285.


Abstract

Whole-day ambulatory monitoring is used for diagnosing hypertension and for judging response to treatment. We evaluated both of these properties in an antihypertensive trial with the calcium channel blocker diltiazem hydrochloride. Measured by a conventional sphygmomanometer, systolic and diastolic blood pressures fell significantly in patients who received diltiazem, whereas no consistent changes occurred in those who received placebo. Administration of the drug also decreased systolic and diastolic blood pressures evenly throughout the day, as determined by automated monitoring. The 15 diltiazem-treated patients were subdivided into those whose clinically diagnosed hypertension was confirmed by pretreatment blood pressure monitoring (24-hour average diastolic blood pressure, ≥90 mm Hg; n=9) and those whose 24-hour blood pressures failed to meet this criterion (n=6). Diltiazem therapy decreased average whole-day blood pressures by 18/13 mm Hg in the hypertensives but by only 0/1 mm Hg in the others. Thus, whole-day blood pressure monitoring strengthens antihypertensive trials by documenting efficacy and duration of treatment. In addition, it enhances the diagnosis of hypertension, thereby identifying those patients in whom treatment seems justified.

(JAMA 1988;259:3281-3285)



Author Affiliations

From the Hypertension Center, Veterans Administration Medical Center, Long Beach, Calif; and the University of California, Irvine.


Footnotes

Reprint requests to Veterans Administration Medical Center, W130, 5901 E Seventh St, Long Beach, CA 90822 (Dr Weber).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ambulatory Blood Pressure Monitoring in Children and Adolescents
Simckes et al.
CLIN PEDIATR 2002;41:549-564.
ABSTRACT  

Antihypertensive Treatment Efficacy in Type II Diabetes Mellitus : Dissociation Between Casual and 24-Hour Ambulatory Blood Pressure
Puig et al.
Hypertension 1995;26:1093-1099.
ABSTRACT | FULL TEXT  

Blood Pressure Effects of the Angiotensin II Receptor Blocker, Losartan
Weber et al.
Arch Intern Med 1995;155:405-411.
ABSTRACT  

National High Blood Pressure Education Program Working Group Report on Ambulatory Blood Pressure Monitoring
The National High Blood Pressure Education Program
Arch Intern Med 1990;150:2270-2280.
ABSTRACT  

Errors in Table.
JAMA 1990;264:1411-1411.
ABSTRACT  

Assessing Duration of Antihypertensive Effects With Whole-Day Blood Pressure Monitoring
Cheung et al.
Arch Intern Med 1989;149:2021-2025.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.